Want to build the next generation of lab automation platforms?

Let’s talk frankly.

If it’s true that biotech in the next thirty years will have a similar impact to what ICT has been provided in the last thirty, then, one can be pretty sure that no company have enough resources to provide all solutions. That is why traditional firms in the 21th century have to disappear, leaving space to the galvanizing message of platforms able to redefine entire markets.

Our platform aims at providing life scientists with delightful and meaningful research experience.

We do this by bundling available components from wasteful supply chains, and by connecting untapped human value in crafting the next generation of lab automation platform.

In biology and clinical laboratories, hours of manual work are a compulsory part of the experiments and diagnostic protocols. In the past decades, a big effort has been done to develop machines (e.g. pipetting robots) that would automate some of the recurrent tasks in a molecular biology lab (pipetting, cell culture, analysis, labelling and tracking of samples etc.).

Despite the effort, these machines are: large sized, task-specific, difficult to use, and most importantly, extremely expensive. In fact, there is a very fragmented market of lab automation that is currently under served. The only way to address those kind of long tail markets is to build infrastructural components and interfaces that enable and empower end users, businesses and professionalized entities to recombine, reconfigure and customize these bits and pieces. We want to serve customers’ delight and appreciation by providing custom low to medium throughput solutions.

We want to offer the world a full stack of lab automation components that can be scaled up as needed. Join us.

We believe that scientists should spend their time thinking on their research not on their machines.

An Outlook on Droplet Microfluidics

Lab-on-a-chip devices reduce by many folds the quantity of samples (scarce) and reagents (expensive), in order to perform biochemical reactions. Moreover, such devices reduce the reaction time by increasing the surface-to-volume ratio, and they allow for exquisite controllability of reaction conditions providing high end stimulation and sensing (e.g. electrical or optical) mechanisms.

Once slow and difficult to setup even for an average end consumer (e.g bio-molecular researcher), we are now moving the industry towards general purpose, high speed, and easy multiplexing solutions.

Digital microfluidics (DMF) or Droplets Microfluidics, is now a huge and mature trend in the field of nanobiotechnology, and after more than 20 years of development it is now showing to outperform on several dimensions other microfluidics systems, making it the best candidate for mass production of a wide range of commercial applications. It is suitable for a large plethora of biological assays, from high precision sample preparations, to lab-on-a-chip applications as well as point-of-care applications. Ultimately, an experimental biology that can be programmed provides faster and reproducible results.

Request our prototype and start to explore what you can do with our platform.

Get your hands on an OpenDrop v2 to explore the potential of DMF technology in molecular biology and healthcare.

Already playing with DMF? Join our next webinar to learn more.

Learn how to use your OpenDrop or to leverage any other EWOD-based DMF for your projects. Our webinars feature top experts in the field of microelectronics, biochip design and molecular biology.
Join the revolution of programmable biology today.

Date Instructors Description Tickets
Jan 2017 (TBA) Urs Gaudenz, Ruediger Trojok Digital Biology Academy 101: Hands-on introduction on moving droplets at home Reserve your spot

Stay tuned for updates